258 related articles for article (PubMed ID: 22807579)
1. Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion.
Saintigny P; Peng S; Zhang L; Sen B; Wistuba II; Lippman SM; Girard L; Minna JD; Heymach JV; Johnson FM
Mol Cancer Ther; 2012 Sep; 11(9):2021-32. PubMed ID: 22807579
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the receptor tyrosine kinase EphA4 in human gastric cancers.
Oki M; Yamamoto H; Taniguchi H; Adachi Y; Imai K; Shinomura Y
World J Gastroenterol; 2008 Oct; 14(37):5650-6. PubMed ID: 18837080
[TBL] [Abstract][Full Text] [Related]
3. Sizes of interface residues account for cross-class binding affinity patterns in Eph receptor-ephrin families.
Guo FY; Lesk AM
Proteins; 2014 Mar; 82(3):349-53. PubMed ID: 24105818
[TBL] [Abstract][Full Text] [Related]
4. Eph-ephrin A system regulates human choriocarcinoma-derived JEG-3 cell invasion.
Fujiwara H; Nishioka Y; Matsumoto H; Suginami K; Horie A; Tani H; Matsumura N; Baba T; Sato Y; Araki Y; Konishi I
Int J Gynecol Cancer; 2013 Mar; 23(3):576-82. PubMed ID: 23429488
[TBL] [Abstract][Full Text] [Related]
5. Eph/ephrin profiling in human breast cancer reveals significant associations between expression level and clinical outcome.
Brantley-Sieders DM; Jiang A; Sarma K; Badu-Nkansah A; Walter DL; Shyr Y; Chen J
PLoS One; 2011; 6(9):e24426. PubMed ID: 21935409
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Eph receptor A4 by 2,5-dimethylpyrrolyl benzoic acid suppresses human pancreatic cancer growing orthotopically in nude mice.
Takano H; Nakamura T; Tsuchikawa T; Kushibiki T; Hontani K; Inoko K; Takahashi M; Sato S; Abe H; Takeuchi S; Sato N; Hiraoka K; Nishihara H; Shichinohe T; Hirano S
Oncotarget; 2015 Dec; 6(38):41063-76. PubMed ID: 26516928
[TBL] [Abstract][Full Text] [Related]
7. Structural plasticity of eph receptor A4 facilitates cross-class ephrin signaling.
Bowden TA; Aricescu AR; Nettleship JE; Siebold C; Rahman-Huq N; Owens RJ; Stuart DI; Jones EY
Structure; 2009 Oct; 17(10):1386-97. PubMed ID: 19836338
[TBL] [Abstract][Full Text] [Related]
8. EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth.
Iiizumi M; Hosokawa M; Takehara A; Chung S; Nakamura T; Katagiri T; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H
Cancer Sci; 2006 Nov; 97(11):1211-6. PubMed ID: 16965393
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of Eph receptors and ephrins in the cochlear ganglion and eighth cranial nerve of the chick embryo.
Siddiqui SA; Cramer KS
J Comp Neurol; 2005 Feb; 482(4):309-19. PubMed ID: 15669077
[TBL] [Abstract][Full Text] [Related]
10. Identification of the Jak/Stat proteins as novel downstream targets of EphA4 signaling in muscle: implications in the regulation of acetylcholinesterase expression.
Lai KO; Chen Y; Po HM; Lok KC; Gong K; Ip NY
J Biol Chem; 2004 Apr; 279(14):13383-92. PubMed ID: 14729671
[TBL] [Abstract][Full Text] [Related]
11. Stem-like Cells from Invasive Breast Carcinoma Cell Line MDA-MB-231 Express a Distinct Set of Eph Receptors and Ephrin Ligands.
Lucero M; Thind J; Sandoval J; Senaati S; Jimenez B; Kandpal RP
Cancer Genomics Proteomics; 2020; 17(6):729-738. PubMed ID: 33099474
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Eph receptor-ephrin ligand interaction by tea polyphenols.
Noberini R; Koolpe M; Lamberto I; Pasquale EB
Pharmacol Res; 2012 Oct; 66(4):363-73. PubMed ID: 22750215
[TBL] [Abstract][Full Text] [Related]
13. EPH/ephrin profile and EPHB2 expression predicts patient survival in breast cancer.
Husa AM; Magić Ž; Larsson M; Fornander T; Pérez-Tenorio G
Oncotarget; 2016 Apr; 7(16):21362-80. PubMed ID: 26870995
[TBL] [Abstract][Full Text] [Related]
14. Eph/Ephrin signaling regulates the mesenchymal-to-epithelial transition of the paraxial mesoderm during somite morphogenesis.
Barrios A; Poole RJ; Durbin L; Brennan C; Holder N; Wilson SW
Curr Biol; 2003 Sep; 13(18):1571-82. PubMed ID: 13678588
[TBL] [Abstract][Full Text] [Related]
15. Distinctive binding of three antagonistic peptides to the ephrin-binding pocket of the EphA4 receptor.
Lamberto I; Qin H; Noberini R; Premkumar L; Bourgin C; Riedl SJ; Song J; Pasquale EB
Biochem J; 2012 Jul; 445(1):47-56. PubMed ID: 22489865
[TBL] [Abstract][Full Text] [Related]
16. Regulation of EphA 4 kinase activity is required for a subset of axon guidance decisions suggesting a key role for receptor clustering in Eph function.
Egea J; Nissen UV; Dufour A; Sahin M; Greer P; Kullander K; Mrsic-Flogel TD; Greenberg ME; Kiehn O; Vanderhaeghen P; Klein R
Neuron; 2005 Aug; 47(4):515-28. PubMed ID: 16102535
[TBL] [Abstract][Full Text] [Related]
17. Expression profiling of the ephrin (EFN) and Eph receptor (EPH) family of genes in atherosclerosis-related human cells.
Sakamoto A; Sugamoto Y; Tokunaga Y; Yoshimuta T; Hayashi K; Konno T; Kawashiri MA; Takeda Y; Yamagishi M
J Int Med Res; 2011; 39(2):522-7. PubMed ID: 21672356
[TBL] [Abstract][Full Text] [Related]
18. Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred.
Prevost N; Woulfe D; Tanaka T; Brass LF
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9219-24. PubMed ID: 12084815
[TBL] [Abstract][Full Text] [Related]
19. Insights into Eph receptor tyrosine kinase activation from crystal structures of the EphA4 ectodomain and its complex with ephrin-A5.
Xu K; Tzvetkova-Robev D; Xu Y; Goldgur Y; Chan YP; Himanen JP; Nikolov DB
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14634-9. PubMed ID: 23959867
[TBL] [Abstract][Full Text] [Related]
20. EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line.
Fukai J; Yokote H; Yamanaka R; Arao T; Nishio K; Itakura T
Mol Cancer Ther; 2008 Sep; 7(9):2768-78. PubMed ID: 18790757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
